Featured Biotech ETFs Are Already Benefitting from Pfizer Vaccine’s Full Approval By Ian YoungAugust 23, 2021
Innovative ETFs Channel Will Biotech ETFs Benefit from Biogen’s New Alzheimer’s Drug? By Ian YoungJune 9, 2021
Equity ETF Channel Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause By Ian YoungApril 13, 2021
Featured Moderna Helps Biotech ETFs Mitigate Massive Losses as Stocks Tumble By Ian YoungJanuary 4, 2021
Featured As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally By Ian YoungDecember 3, 2020
Nasdaq Investment Intelligence Channel A Junior Biotech ETF With Home Run Potential By Todd ShriberAugust 14, 2020
